Clinical Trial Details

Trial ID: L0784
Source ID: NCT03749070
Associated Drug: Silymarin
Title: Efficacy of Silymarin in Patients With Non-alcoholic Fatty Liver Disease - The SILIVER Trial: Randomized Clinical Trial
Acronym: --
Status: Recruiting
Study Results: No Results Available
Results: --
Conditions: Non-Alcoholic Fatty Liver Disease
Interventions: Dietary Supplement: Silymarin
Outcome Measures: Absence or change in NAFLD degreeLipid profile;Fasting blood glucose;Glycated haemoglobin;Insulin;Serum Iron;Transferrin saturation;Serum ferritin;Hepatic transaminases;gamma glutamyl transferase
Sponsor/Collaborators: Camila Ribeiro de Avelar
Gender: All
Age: 20 Years60 Years
Phases: Not applicable
Enrollment: 132
Study Type: Interventional
Study Designs: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Start Date: 28/10/2018
Completion Date: --
Results First Posted: --
Last Update Posted: 7 February 2022
Locations: Brazil
URL: https://clinicaltrials.gov/show/NCT03749070